Prognostic role of CD133 expression in colorectal cancer: a meta-analysis
Published 2012 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Prognostic role of CD133 expression in colorectal cancer: a meta-analysis
Authors
Keywords
-
Journal
BMC CANCER
Volume 12, Issue 1, Pages -
Publisher
Springer Nature
Online
2012-12-06
DOI
10.1186/1471-2407-12-573
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Combined CD133/CD44 Expression as a Prognostic Indicator of Disease-Free Survival in Patients With Colorectal Cancer
- (2012) Gennaro Galizia ARCHIVES OF SURGERY
- Understanding cancer stem cell heterogeneity and plasticity
- (2012) Dean G Tang CELL RESEARCH
- Increased expression of CD133 and reduced dystroglycan expression are strong predictors of poor outcome in colon cancer patients
- (2012) Claudio Coco et al. JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH
- Immunohistochemical detection of CD133 is associated with tumor regression grade after chemoradiotherapy in rectal cancer
- (2012) Kumiko Hongo et al. MEDICAL ONCOLOGY
- Common Cancer Stem Cell Gene Variants Predict Colon Cancer Recurrence
- (2011) A. Gerger et al. CLINICAL CANCER RESEARCH
- The expression pattern of aldehyde dehydrogenase 1 (ALDH1) is an independent prognostic marker for low survival in colorectal tumors
- (2011) Tobias Vogler et al. EXPERIMENTAL AND MOLECULAR PATHOLOGY
- Clinicopathological significance and prognostic value of EphA3 and CD133 expression in colorectal carcinoma
- (2011) H.-Q. Xi et al. JOURNAL OF CLINICAL PATHOLOGY
- The prognostic role of cancer stem cells in breast cancer: a meta-analysis of published literatures
- (2010) Liheng Zhou et al. BREAST CANCER RESEARCH AND TREATMENT
- Prognostic impact of the expression of putative cancer stem cell markers CD133, CD166, CD44s, EpCAM and ALDH1 in colorectal cancer
- (2010) A Lugli et al. BRITISH JOURNAL OF CANCER
- CD133 expression predicts for non-response to chemotherapy in colorectal cancer
- (2010) Chee W Ong et al. MODERN PATHOLOGY
- Frequency and pattern of expression of the stem cell marker CD133 have strong prognostic effect on the surgical outcome of colorectal cancer patients
- (2010) Takahashi ONCOLOGY REPORTS
- Prognostic Significance of the Cancer Stem Cell Markers CD133, CD44, and CD166 in Colorectal Cancer
- (2009) David Horst et al. CANCER INVESTIGATION
- Tumour CD133 mRNA expression and clinical outcome in surgically resected colorectal cancer patients
- (2009) R. Artells et al. EUROPEAN JOURNAL OF CANCER
- Cancer stem cell marker CD133+ tumour cells and clinical outcome in rectal cancer
- (2009) Qi Wang et al. HISTOPATHOLOGY
- Apoptosis signaling in cancer stem cells
- (2009) Simone Fulda et al. INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY
- ABC Transporters, Drug Resistance, and Cancer Stem Cells
- (2009) Michael Dean JOURNAL OF MAMMARY GLAND BIOLOGY AND NEOPLASIA
- Higher percentage of CD133+ cells is associated with poor prognosis in colon carcinoma patients with stage IIIB
- (2009) Chun-Yan Li et al. Journal of Translational Medicine
- Cancer stem cell markers CD133 and CD24 correlate with invasiveness and differentiation in colorectal adenocarcinoma
- (2009) Dongho Choi et al. WORLD JOURNAL OF GASTROENTEROLOGY
- Immunohistochemical detection of CD133 expression in colorectal cancer: A clinicopathological study
- (2008) Motohiro Kojima et al. CANCER SCIENCE
Find the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
SearchBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started